Welcome to our dedicated page for The Scotts Miracle-Gro Company news (Ticker: $SMG), a resource for investors and traders seeking the latest updates and insights on The Scotts Miracle-Gro Company stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect The Scotts Miracle-Gro Company's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of The Scotts Miracle-Gro Company's position in the market.
The Scotts Miracle-Gro Company (NYSE: SMG) reported strong second-quarter results with U.S. Consumer net sales hitting a record high of $1.38B, GAAP EPS of $2.74, and non-GAAP Adjusted EPS of $3.69. The company exceeded operating plan targets, improved gross margin, and generated strong free cash flow. Despite total sales being flat at $1.53B, the U.S. Consumer segment increased by 2%. Hawthorne segment sales declined by 28% due to strategic changes. The Company's financial position remains strong with net leverage of 6.95x, well below covenant maximum, and aims to achieve fiscal 2024 guidance.